Background The outcomes after mitral valve transcatheter edge-to-edge repair (M-TEER) for
the patients with severe mitral regurgitation (MR) in hemodynamically unstable conditions …

Background Data on the efficacy of transcatheter edge-to-edge repair (TEER) in patients
with cardiogenic shock (CS) are limited. Objectives This study investigated the …

Background Evidence for transcatheter edge-to-edge mitral valve repair (TEER) for mitral
regurgitation (MR) in patients with cardiogenic shock (CS) is limited. We aimed to investigate …

Background Patients presenting with severe mitral valve regurgitation (MR) and cardiogenic
shock (CS) demonstrate a poor prognosis and high mortality rate. Transcatheter edge-to …

Background There is currently little evidence for transcatheter edgetoedge mitral valve
repair (TEER) for mitral regurgitation (MR) in patients with cardiogenic shock (CS) …

Background Clinical trials have demonstrated the efficacy and safety of mitral transcatheter
edge-to-edge repair (M-TEER) for selected patients with severe mitral regurgitation …

Background: Transcatheter edge-to-edge mitral valve repair (TEER) has been established
as a therapy for severe symptomatic mitral regurgitation (MR) in stable patients, and it has …

Objectives The aim of this study was to determine clinical and echocardiographic
characteristics, mechanisms of failure, and outcomes of mitral valve (MV) surgery after …

Background The management of severe mitral regurgitation (MR) after transcatheter edge
toedge repair (TEER) remains a clinical conundrum. Considering the growing volume of …

Background Mitral transcatheter edge-to-edge repair (M-TEER) is a guideline-
recommended treatment option for patients with severe symptomatic mitral regurgitation …